Planning Committee

Program: Robert Austin FIZ Karlsruhe
  Qin Meng Amgen Inc
  Suzanne Robins Patent Information Services Inc.
  Elyse Turner Merck &Co. Inc
  Donald Walter Thomson Scientific
Evaluation: Sian Griffiths Millennium Pharmaceuticals, Inc
Registration: Ken Koubek Rohm & Haas Company
  Kim Spytek Nerac, Inc
Fundraising: Christine Geluk Eisai Research Institute of Boston, Inc
Site Selection: Amy Dasch Genzyme Corp
Planning/Travel: Qin Meng Amgen Inc
Web Pages: Rick Williams Vertex Pharmaceuticals, Inc
  Tom Wolff Wolff Information Consulting LLC
Meeting Book: Alison Taylor Threshold Information Inc.